These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27431309)
1. Interleukin-10 attenuates tumour growth by inhibiting interleukin-6/signal transducer and activator of transcription 3 signalling in myeloid-derived suppressor cells. Lee BR; Kwon BE; Hong EH; Shim A; Song JH; Kim HM; Chang SY; Kim YJ; Kweon MN; Youn JI; Ko HJ Cancer Lett; 2016 Oct; 381(1):156-64. PubMed ID: 27431309 [TBL] [Abstract][Full Text] [Related]
2. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3. Tang Q; Jiang J; Liu J Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948 [TBL] [Abstract][Full Text] [Related]
3. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937 [TBL] [Abstract][Full Text] [Related]
4. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression. Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Miao JW; Liu LJ; Huang J Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843 [TBL] [Abstract][Full Text] [Related]
6. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment. Ren C; Cheng X; Lu B; Yang G Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway. Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428 [TBL] [Abstract][Full Text] [Related]
8. Tumor NLRP3-Derived IL-1β Drives the IL-6/STAT3 Axis Resulting in Sustained MDSC-Mediated Immunosuppression. Tengesdal IW; Dinarello A; Powers NE; Burchill MA; Joosten LAB; Marchetti C; Dinarello CA Front Immunol; 2021; 12():661323. PubMed ID: 34531850 [TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma. Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776 [TBL] [Abstract][Full Text] [Related]
10. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling. Peng D; Tanikawa T; Li W; Zhao L; Vatan L; Szeliga W; Wan S; Wei S; Wang Y; Liu Y; Staroslawska E; Szubstarski F; Rolinski J; Grywalska E; Stanisławek A; Polkowski W; Kurylcio A; Kleer C; Chang AE; Wicha M; Sabel M; Zou W; Kryczek I Cancer Res; 2016 Jun; 76(11):3156-65. PubMed ID: 27197152 [TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285 [TBL] [Abstract][Full Text] [Related]
12. Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis. Neo SY; Tong L; Chong J; Liu Y; Jing X; Oliveira MMS; Chen Y; Chen Z; Lee K; Burduli N; Chen X; Gao J; Ma R; Lim JP; Huo J; Xu S; Alici E; Wickström SL; Haglund F; Hartman J; Wagner AK; Cao Y; Kiessling R; Lam KP; Westerberg LS; Lundqvist A Sci Transl Med; 2024 May; 16(747):eadi2952. PubMed ID: 38748775 [TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells. Guha P; Gardell J; Darpolor J; Cunetta M; Lima M; Miller G; Espat NJ; Junghans RP; Katz SC Oncogene; 2019 Jan; 38(4):533-548. PubMed ID: 30158673 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling pathway inhibition in clear cell carcinoma of the ovary. Yanaihara N; Hirata Y; Yamaguchi N; Noguchi Y; Saito M; Nagata C; Takakura S; Yamada K; Okamoto A Mol Carcinog; 2016 May; 55(5):832-41. PubMed ID: 25856562 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S Am J Pathol; 2007 Jun; 170(6):2149-58. PubMed ID: 17525280 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221 [TBL] [Abstract][Full Text] [Related]
17. Fungal pattern receptors down-regulate the inflammatory response by a cross-inhibitory mechanism independent of interleukin-10 production. Rodríguez M; Márquez S; de la Rosa JV; Alonso S; Castrillo A; Sánchez Crespo M; Fernández N Immunology; 2017 Feb; 150(2):184-198. PubMed ID: 27709605 [TBL] [Abstract][Full Text] [Related]
18. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma. Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815 [TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer. Ko HJ; Kim YJ Arch Pharm Res; 2016 Nov; 39(11):1597-1608. PubMed ID: 27572156 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]